As of 2025-06-15, the Relative Valuation of Alexion Pharmaceuticals Inc (ALXN) is 48.12 USD. This relative valuation is based on P/E multiples. With the latest stock price at 182.50 USD, the upside of Alexion Pharmaceuticals Inc based on Relative Valuation is -73.6%.
The range of the Relative Valuation is 30.32 - 64.10 USD.
| Range | Selected | |
| Trailing P/E multiples | 14.7x - 20.8x | 18.2x |
| Forward P/E multiples | 11.7x - 20.6x | 15.4x |
| Fair Price | 30.32 - 64.10 | 48.12 |
| Upside | -83.4% - -64.9% | -73.6% |
| Date | P/E |